The groundbreaking therapy of the medication represents a major advance in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide740818.blogdeazar.com/42382958/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment